Evaxion RAVEN - Third Proprietary AI Platform - Viral Disease
RAVEN is our third proprietary AI platform that brings our unique, machine learning approach to vaccine design and development for viral diseases. RAVEN combines the essential AI tools from our PIONEER platform with structural bioinformatic tools from EDEN to arrive at a novel potent T- and B-cell vaccine design for emerging and mutating viral diseases.
-
Most popular related searches
Advantages:
- Promiscuous T-cell Epitopes: Provides high coverage of the entire immunological diversity of the human population
- Multiple Hits on Target: Effectively targets same infected cells and curtails spread of infection via combination of potent epitopes in one vaccine
- Coverage of Entire Viral Cycle: T-cell epitopes kill infected cells at any stage of the viral replication cycle
- Mutation Proof: Strain covered by >5 conserved T-cell epitopes reduces effect of mutation on vaccine efficacy
- Neutralizing Focused: Protein antigen design for generation of neutralizing antibodies
- Broadly Applicable: Platform approach applies to any known virus
Customer reviews
No reviews were found for Evaxion RAVEN - Third Proprietary AI Platform - Viral Disease. Be the first to review!